Enzyme vs Maple Finance — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Maple Finance trades at Rp3,447 (market cap Rp4,09T, Rp309,48M 24h volume). The key difference: Maple Finance is far larger — about 30492.8× Enzyme's market cap, and Enzyme's circulating supply is 3,3M MLN versus 1,2B SYRUP for Maple Finance. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Maple Finance for 13 Days on average.
| MLN | SYRUP | |
|---|---|---|
Market Cap | Rp134,13M | Rp4,09T |
Volume (24h) | Rp104,56M | Rp309,48M |
Circulating Supply | 3,3M MLN | 1,2B SYRUP |
Typical Hold Time | 28 Days | 13 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Maple Finance (SYRUP) trades at Rp3,445 with a market cap of Rp4.1T, showing a bullish technical signal supported by moving averages. Key indicators include RSI_12 at 78.73 (sell signal) and ADX above 45 indicating a strong trend. Support lies at Rp3,290 and resistance at Rp3,594. No major protocol updates or ecosystem news were found recently.
Overall outlook is cautiously optimistic due to strong trend signals, but overbought RSI suggests near-term pullback risk. Opportunities include potential breakout above resistance; major risks involve high volatility and lack of recent fundamental catalysts. Investors should monitor volume and key levels closely.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →Maple, launched in 2021, is an on-chain asset manager that combines decades of experience in traditional finance and cryptocurrency. By merging capital markets expertise with DeFi innovation, Maple offers a variety of products, including secured lending, Bitcoin yield strategies, and structured financial instruments.
Read more on SYRUP →